Stay updated on Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial record for the ASN002 study in moderate-to-severe atopic dermatitis is available again, with its study design, eligibility details, locations, and results information. The record indicates the study was terminated and is no longer recruiting participants.SummaryDifference62%

- Check11 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record details, indicating the study information is currently inaccessible.SummaryDifference17%

- Check60 days agoChange DetectedThe page revision label changed from Revision: v3.6.6 to Revision: v3.7.0, indicating a new site revision. This update does not modify the study content or data on the page.SummaryDifference0.0%

Stay in the know with updates to Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page.